Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#33 / 33 Total
PRTA - Prothena Corporation plc - Stock Price Chart
TickerPRTA [NASD, RUT]
CompanyProthena Corporation plc
CountryIreland
IndustryBiotechnology
Market Cap1.33BEPS (ttm)-2.80
P/E-EPS this Y-78.59%
Forward P/E-EPS next Y12.22%
PEG-EPS past 5Y6.83%
P/S14.51EPS next 5Y34.07%
P/B2.36EPS Q/Q-1169.13%
Dividend-Sales Q/Q-99.37%
Insider Own13.65%Inst Own98.80%
Insider Trans-0.39%Inst Trans-4.11%
Short Float13.47%EarningsFeb 15/a
Analyst Recom1.40Target Price67.78
Avg Volume827.68K52W Range24.28 - 79.65
Prothena Corp. Plc is a clinical-stage neuroscience company, which engages in the discovery and development of novel therapies to change the course of devastating diseases. The firm's clinical pipeline includes both wholly owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Walker Karin LChief Accounting OfficerJan 24 '24Option Exercise13.535,00067,6505,000Jan 24 07:01 PM
Walker Karin LChief Accounting OfficerJan 24 '24Sale34.005,000170,0000Jan 24 07:01 PM
Walker Karin LChief Accounting OfficerDec 20 '23Option Exercise13.535,00067,6505,000Dec 20 07:17 PM
Walker Karin LChief Accounting OfficerDec 20 '23Sale37.195,000185,9520Dec 20 07:17 PM
Walker Karin LChief Accounting OfficerNov 30 '23Option Exercise13.535,00067,6505,000Nov 30 06:24 PM
1234